Precise vs Pragmatic - Perspective & Evaluation of Lipoprotein(a) Testing Recommendations: Outstanding article by ⭐️⚽️ player & the #JA17 Fellow in Preventive 🫀Dr. Alex Razavi ⁦Josh Allen⁩ ⁦Buffalo Bills⁩ ⁦Emory Cardiology⁩ #🥍🏏🏈⚽️🏀 sciencedirect.com/science/articl…

📢Call-to-action for radiologists📢: campaign to improve reporting of incidental coronary artery calcification (CAC) on routine, non-cardiac chest CT. Systematic review of published investigations reveals: ✅CAC often visualized on routine chest CT ✅new diagnosis in many adults

Big thank you to the whole team Leslee Shaw DBerman Matthew Budoff MD Nathan Wong VVaccarino Marly van Assen Carlo N. De Cecco, MD, PhD AQuyyumi Anurag Mehta Paul Muntner Michael Miedema Alan Rozanski, MD Dr. John A Rumberger, PhD, MD, FACC, MSCCT Khurram Nasir Roger Blumenthal LSperling Martin Bødtker Mortensen Seamus Whelton Michael J. Blaha Omar Dzaye

Our CAC percentile calculator for ages 30-45 years has been upgraded! In use for clinical CAC score reporting and now works on mobile: cac-tools.com #YesCCT #HeartMonth Dr. Todd C. Villines Michael J. Blaha Roger Blumenthal Pamela Johnson Johns Hopkins Ciccarone Center

High-Risk ‘Clues’ Add 💪🏾to Calcium Scores in Primary Prevention | tctmd.com - led by the #JA17 of Prevention-Buffalo native ⁦Alexander C. Razavi⁩ ⁦Omar Dzaye⁩ ⁦Michael J. Blaha⁩ ⁦Johns Hopkins Ciccarone Center⁩ ⁦Johns Hopkins Cardiology⁩ #🥍🏏🏈⛳️ tctmd.com/news/high-risk…

Aortic valve disease is often identified too late before clinicians can provide meaningful prevention. Listen to Drs. Richard A. Chazal & Michael J. Blaha discuss Prevalence of Aortic Valve Calcium & the Long-Term Risk of Incident Severe Aortic Stenosis: bit.ly/4a4QtQ2

PREVENT Equations: A New Era in CVD Risk Assessment. A perspective piece led by Roger Blumenthal Alexander C. Razavi and colleagues #AHAJournals John William McEvoy Dr. Payal Kohli, MD Seamus Whelton ahajrnls.org/3PH4sU1

New PREVENT Equations for CVD Risk Assessment: Key Takeaways - excellent summary of commentary led by Dr. Alex Razavi ⁦Emory Cardiology⁩ ⁦Johns Hopkins Ciccarone Center⁩ ⁦Seamus Whelton⁩ ⁦Johns Hopkins Cardiology⁩ ⁦Johns Hopkins Medicine⁩ acc.org/latest-in-card…

It has been a great honor to serve as chair of the American College of Cardiology #CVPrev section for the past 3 years. Special thanks to Kim Kooi for supporting me. I know I am leaving the section in great hands Eugenia Gianos MD

Always good to reunite with the head of the ☘️🇮🇪 component of the ⁦Johns Hopkins Ciccarone Center⁩ ⁦John William McEvoy⁩ ⁦Seamus Whelton⁩

Our new JACC paper shows in a large diverse US cohort Lp(a) to predict long-term ASCVD and stronger in those w/DM, supporting recent recommendations for all adults to get #lpa tested. sciencedirect.com/science/articl… UCI Health Physicians UCI Cardiology ASPC National Lipid Association JACC Journals

Great resource! Thanks for sharing!!

Congratulations John William McEvoy on this well deserved award! I forget your sports name per Roger Blumenthal but your work is amazing! #ESCPrev2024 #CVPrev Khurram Nasir Michael D. Shapiro Seth Martin Erin D. Michos, M.D. NIPC

Check out our recent publication on AVC showing a stepwise increased risk of incident dementia even after adjusting for atherosclerotic risk factors and CAC scores. atherosclerosis-journal.com/article/S0021-… Jelani K. Grant Roger Blumenthal Seamus Whelton Johns Hopkins Ciccarone Center Alexander C. Razavi

Roger Blumenthal WilliamZoghbi Khurram Nasir Johns Hopkins Ciccarone Center Johns Hopkins Cardiology Johns Hopkins Medicine Houston Methodist 👑 Congratulations Khurram Nasir

Our new Circ: CV Imaging paper shows that AVC is the preferred prognostic risk marker to identify patients at risk for severe AS, regardless of Lp(a) or LDL-C level. ahajournals.org/eprint/UUV5JYU… Natalie Marrero Roger Blumenthal Alexander C. Razavi Matthew Budoff MD Michael J. Blaha Sanjiv J. Shah, MD Johns Hopkins Ciccarone Center

Long wanted to tackle this topic close to my heart Opening Pandora's box on #PowerOfZero Resilience in Genetic Dyslipidemia! Let's explore why there's so much controversy and resistance—and the incredible implications and possibilities if we open our minds ahajournals.org/doi/10.1161/CI…

Superb, thought provoking writing here by Khurram. Excellent summary of the complexity of the ASCVD process.

CAC/CCTA is the Imaging Modality of Choice in Refining ASCVD Risk in Primary Prevention... YAY or NAY?? Find out who wins the battle between Seamus Whelton and Matthew Budoff MD! Registration open through Aug. 1 at aspconline.org/2024congress @drmarthagulati @drmichaelshapir

Seamus Whelton 🥊 Matthew Budoff MD #ASPC2024 #greatdebates CAC 🆚 CCTA for primary prevention ♥️SW: data supports CAC, guidelines followed. Great tool to refine risk assessment in primary prevention & CTA doesn’t improve it 💙MB: plaque character matters, non calcified plaque #YesSCCT